Literature DB >> 6176858

Specificities of human heterophilic Hanganutziu and Deicher (H-D) antibodies and avian antisera against H-D antigen-active glycosphingolipids.

Y Fujii, H Higashi, K Ikuta, S Kato, M Naiki.   

Abstract

The precise specificities H-D antibodies and newly obtained avian antisera to the H-D antigen-active glycosphingolipids. N-glycolylneuraminyl (alpha 2-3) lactosyl ceramide (hematoside) and N-glycolylneuraminyl (alpha 2-3) lactoneotetraosyl ceramide (sialosylparagloboside) were compared by gel precipitation and hemagglutination inhibition using other gangliosides with a related structure and chemically modified hematoside derivatives and the oligosaccharides from both the antigenic glycosphingolipids. Human H-D antibodies were found to have the same affinity for both antigenic glycosphingolipids; however, the avian anti-hematoside or anti-sialosylparaglobosides showed a higher affinity for the homologous antigen. Human H-D antibodies were directed more exactly toward the terminal sialic acid residue and more roughly to the hydrophobic portion of both compounds; however, the two avian antibodies were directed more specificity to the whole structure of the homologous antigen glycosphingolipid.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6176858     DOI: 10.1016/0161-5890(82)90250-4

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  15 in total

1.  Sialic acid species as a determinant of the host range of influenza A viruses.

Authors:  Y Suzuki; T Ito; T Suzuki; R E Holland; T M Chambers; M Kiso; H Ishida; Y Kawaoka
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

Review 2.  Multifarious roles of sialic acids in immunity.

Authors:  Ajit Varki; Pascal Gagneux
Journal:  Ann N Y Acad Sci       Date:  2012-04       Impact factor: 5.691

3.  Ganglioside epitope recognized by K99 fimbriae from enterotoxigenic Escherichia coli.

Authors:  E Ono; K Abe; M Nakazawa; M Naiki
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

4.  Characterization of a polyclonal anti-Galalpha1-3Gal antibody from chicken.

Authors:  J F Bouhours; C Richard; N Ruvoen; N Barreau; J Naulet; D Bouhours
Journal:  Glycoconj J       Date:  1998-01       Impact factor: 2.916

5.  Identification of O-glycan Structures from Chicken Intestinal Mucins Provides Insight into Campylobactor jejuni Pathogenicity.

Authors:  Weston B Struwe; Ronan Gough; Mary E Gallagher; Diarmuid T Kenny; Stephen D Carrington; Niclas G Karlsson; Pauline M Rudd
Journal:  Mol Cell Proteomics       Date:  2015-03-16       Impact factor: 5.911

6.  Evidence for a free N-acetylneuraminic acid-hydroxylating enzyme in pig mandibular gland soluble fraction.

Authors:  C J Mukuria; W D Mwangi; A Noguchi; G P Waiyaki; T Asano; M Naiki
Journal:  Biochem J       Date:  1995-01-15       Impact factor: 3.857

7.  Human uptake and incorporation of an immunogenic nonhuman dietary sialic acid.

Authors:  Pam Tangvoranuntakul; Pascal Gagneux; Sandra Diaz; Muriel Bardor; Nissi Varki; Ajit Varki; Elaine Muchmore
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-01       Impact factor: 11.205

Review 8.  Involvement of a non-human sialic Acid in human cancer.

Authors:  Annie N Samraj; Heinz Läubli; Nissi Varki; Ajit Varki
Journal:  Front Oncol       Date:  2014-02-19       Impact factor: 6.244

9.  The analysis of N-glycolylneuraminic acid(NeuGc) of hepatoma tissue and K562 cell ferritins using HPLC and mass spectrometry.

Authors:  Hideo Asakawa; Masataka Sasabe; Ryuunosuke Miyazaki; Haruo Matsuda; Fumio Fukai; Kazuki Hanada; Hisashi Hirano; Seiichi Takasaki
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2006-07       Impact factor: 3.493

10.  Racotumomab: an anti-idiotype vaccine related to N-glycolyl-containing gangliosides - preclinical and clinical data.

Authors:  Ana M Vázquez; Ana M Hernández; Amparo Macías; Enrique Montero; Daniel E Gómez; Daniel F Alonso; Mariano R Gabri; Roberto E Gómez
Journal:  Front Oncol       Date:  2012-10-23       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.